Exact Sciences
EXAS
#1165
Rank
โ‚น1.900 T
Marketcap
โ‚น9,957
Share price
0.00%
Change (1 day)
149.78%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚น15.95 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚น3.24 Billion. , an increase over its 2024 earnings that were of -โ‚น96.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น17.3 Billion-82.05%
2024 -โ‚น96.38 Billion435.05%
2023 -โ‚น18.02 Billion-69.18%
2022 -โ‚น58.45 Billion-25.77%
2021 -โ‚น78.74 Billion1.68%
2020 -โ‚น77.45 Billion271.17%
2019 -โ‚น20.87 Billion58.99%
2018 -โ‚น13.13 Billion20.89%
2017 -โ‚น10.86 Billion-30.95%
2016 -โ‚น15.73 Billion5.09%
2015 -โ‚น14.97 Billion57.24%
2014 -โ‚น9.52 Billion116.53%
2013 -โ‚น4.4 Billion
2011 -โ‚น2.74 Billion143.73%
2010 -โ‚น1.13 Billion27.85%
2009 -โ‚น0.88 Billion0.27%
2008 -โ‚น0.88 Billion-20.95%
2007 -โ‚น1.11 Billion-13.53%
2006 -โ‚น1.29 Billion-10.07%
2005 -โ‚น1.43 Billion-21.81%
2004 -โ‚น1.83 Billion-33.44%
2003 -โ‚น2.74 Billion-6.51%
2002 -โ‚น2.93 Billion17.95%
2001 -โ‚น2.49 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น730.74 B-4,325.25%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
โ‚น5.87 B-133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น6.25 B-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น39.72 Billion 129.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น3.32 Billion-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA